EBV

GPTKB entity

Statements (62)
Predicate Object
gptkbp:instance_of gptkb:virus
gptkbp:associated_cancer gptkb:Oncology
gptkb:nasopharyngeal_carcinoma
gptkbp:associated_with gptkb:chronic_fatigue_syndrome
gptkb:systemic_lupus_erythematosus
gptkb:rheumatoid_arthritis
gptkb:multiple_sclerosis
lymphoproliferative disorders
gptkbp:author gptkb:Michael_Epstein
gptkb:Bert_Achong
gptkb:Yvonne_Barr
gptkbp:complications hepatitis
thrombocytopenia
splenic rupture
gptkbp:diagnosis blood test
gptkbp:discovery gptkb:United_Kingdom
gptkbp:discovery_year gptkb:1964
gptkbp:diseases gptkb:Oncology
gptkb:Burkitt_lymphoma
yes
infectious mononucleosis
gptkbp:epidemiology ubiquitous in human populations
gptkbp:family gptkb:Herpesviridae
gptkbp:full_name gptkb:Epstein-Barr_virus
gptkbp:genus gptkb:Lymphocryptovirus
gptkbp:has_been_restored possible
gptkbp:hosts gptkb:humans
https://www.w3.org/2000/01/rdf-schema#label EBV
gptkbp:incubation_period 4 to 6 weeks
gptkbp:is_compared_to over 90% in adults
gptkbp:is_vulnerable_to no approved vaccine
gptkbp:originated_in B cells
epithelial cells
gptkbp:prevalence common worldwide
gptkbp:propagation_method saliva
gptkbp:replaces Burkitt lymphoma cells
gptkbp:research_focus autoimmune diseases
cancer biology
vaccine development
gptkbp:seed_dispersal double-stranded DNA
gptkbp:serological_markers gptkb:EBNA-Ig_G
EA-Ig G
VCA-Ig G
VCA-Ig M
gptkbp:symptoms fatigue
fever
sore throat
swollen lymph nodes
gptkbp:treatment antivirals
supportive care
corticosteroids
exploring monoclonal antibodies
investigating antiviral therapies
studying immune modulation
gptkbp:viral_entry via oral mucosa
gptkbp:viral_family gptkb:Herpesviridae
gptkbp:viral_genus gptkb:Lymphocryptovirus
gptkbp:viral_infection_type latent and lytic phases
gptkbp:viral_latency establishes lifelong infection
gptkbp:viral_replication in B lymphocytes
gptkbp:bfsParent gptkb:Epstein-Barr_virus
gptkbp:bfsLayer 5